dr. marfu'ah binti nik eezamuddeen

pegawai perubatan ud53

jab radioterapi & onkologi, hukm

 marfuah@ppukm.ukm.edu.my

No. rasmi:
UKM : 03 8921 5555



   Biografi/ Biography :


  • PEGAWAI PERUBATAN UD53




    •     Data Bibliometrik / Bibliometric Data
    Nota : Jumlah penerbitan adalah berdasarkan dari tahun pertama berkhidmat di UKM.
    Note : The number of publication is based from the first year working in UKM.
       Penerbitan Terkini / Latest Publication

    ramesh kumar, beehong soon, fuad ismail, marfuah nik ezzamudden, shahizon azura mohamed mukari, aida widure mustapha mohd mustapha, aida hani mohd kalok, norlia abdullah, ian paddick, siti khadijah hamsan.  (2023).  gamma knife radiosurgery: a safe and effective treatment for brain metastases in pregnancy.  - the 8th meeting of the asian leksell gamma knife society.  135--. 

     
       Penerbitan Lain-lain / Other Publication

    ramesh kumar, beehong soon, fuad ismail, marfuah nik ezzamudden, shahizon azura mohamed mukari, aida widure mustapha mohd mustapha, aida hani mohd kalok, norlia abdullah, ian paddick, siti khadijah hamsan.  (2023).  gamma knife radiosurgery: a safe and effective treatment for brain metastases in pregnancy.  - the 8th meeting of the asian leksell gamma knife society.  135--. 

     
       Geran Kolaborasi Terkini / Latest Collaboration Grant
    Geran / Grant Kolaborator / Collaborator Status
    IMMUNO-CAPTURE OF CIRCULATING GALECTIN 9-BOUND EXTRACELLULAR VESICLES USING SUPERPARAMAGNETIC BEADS VIA CONVENTIONAL FLOW CYTOMETRY biomed global
    17.6% (2023-01-16 sehingga 2024-01-15)
    A RANDOMIZED, OPEN-LABEL, PHASE 3 STUDY OF COSIBELIMAB (CK-301) IN COMBINATION WITH PLATINUM+PEMETREXED CHEMOTHERAPY IN SUBJECTS WITH FIRST-LINE METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER [PROTOCOL NO. CK-301-301] checkpoint therapeutics, inc.
    44.5% (2021-06-10 sehingga 2025-06-09)
    PHASE 1 STUDY INVESTIGATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF THE ANTI‑OX40 AGONIST MONOCLONAL ANTIBODY BGB-A445 IN COMBINATION WITH THE ANTI-PD-1 MONOCLONAL ANTIBODY TISLELIZUMAB IN PATIENTS WITH ADVANCED S beigene singapore pte. ltd
    12% (2022-11-10 sehingga 2025-11-09)
       Projek Penyelidikan / Research Projects
    Projek / Project Tempoh / Period Peranan / Role
    end-of-life communication: a malaysian survey among oncology doctors 27-01-202226-05-2023 Ketua Projek
    immuno-capture of circulating galectin 9-bound extracellular vesicles using superparamagnetic beads via conventional flow cytometry 16-01-202315-01-2024 Penyelidik Bersama
    phase 1 study investigating the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of the anti‑ox40 agonist monoclonal antibody bgb-a445 in combination with the anti-pd-1 monoclonal antibody tislelizumab in patients with advanced s 10-11-202209-11-2025 Penyelidik Bersama
    delineating the immunogenic roles of folfox-induced extracellular vesicles via the toll-like receptor 4 (tlr4) pathway in colorectal cancer 01-09-202231-08-2025 Penyelidik Bersama
    design, efficacy evaluation and clinical validation of a circanapc7 basescope probe for the detection of folfox chemoresistant colorectal cancer via in situ hybridization 01-07-202230-06-2024 Penyelidik Bersama
    Lihat Seterusnya/More
       Bidang Kepakaran / Area of Expertise
    Nota : Maksimum 5 Bidang Kepakaran yang terkini dipaparkan./ Note : Maximum of 5 latest Area of Expertise is viewed.
       Pelajar Seliaan / Supervised Student
    0

    Sarjana /
    Master
    1

    Doktor Falsafah /
    Philosophy Doctor